In May 17-18, Fondazione Don Gnocchi hosted the ENATRANS consortium meeting. ENATRANS is an Horizon 2020 project which aims to network and support SMEs in translation of Nanomedicine in Europe by providing up-to-date information (i.e. approval processes, regulatory authorities and agencies, clinical and market data) and interactive tools.

The central work of the project is the implementation of a Translation Advisory Board (TAB) made of senior experienced translation experts that can support R&D teams (both in SMEs and Academia) in the translation of their research to make it successful in clinical trials and potentially on the market. Besides ENATRANS can provide privileged contacts with the medical, the business or the investment community.

If you are interested in the TAB opportunity check the website: http://www.nanomedtab.eu

Partners in ENATRANS are: VDI/VDE, Nanobiotix, CEA-Leti, bioanalytik-muenster, Tel Aviv University, Fondazione Don Gnocchi and TecMinho